CompletedNot Applicable

A Randomized Patient Preference Trial on Heat-sensitive Moxibustion for Primary Hypertension in Community

China400 participantsStarted 2021-03-10

Plain-language summary

Heat-sensitive moxibustion, an important mean of external therapy of traditional Chinese medicine, has unique advantages in treating various chronic diseases than common moxibustion. This study aims to evaluate the efficacy, safety, and cost-effectiveness of heat-sensitive moxibustion for primary hypertension under community self-management setting using a multicenter, pragmatic, randomized controlled trial design with patient-preference arms.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Diagnosed with essential hypertension, i.e., systolic blood pressure ≥ 140mmHg and/or diastolic blood pressure ≥ 90 mmHg, with a course more than 6 months.
✓. Ages: 18-80 years;
✓. The original antihypertensive drugs are calcium channel blockers and/or angiotensin II receptor blockers.
✓. Did not receive acupoint stimulation therapies for hypertension in the last month.
✓. Patients in the heat-sensitive moxibustion groups need to develop at least one type of moxibustion sensation around the following acupoints: Yongquan, Baihui, Shenque, Quchi, Zusanli, Hegu, Taichong and Dazhui.
✓. Consent to sign an informed consent form

Exclusion criteria

✕. Systolic blood pressure ≥ 180mmHg and/or diastolic blood pressure ≥ 110mmHg after taking antihypertensive drugs;
✕. Secondary hypertension.
✕. Pregnancy and lactation;
✕. Allergic to moxibustion devices, moxa smoke or Artemisia argyi.
✕. Complicated with severe diseases that are not recommended for heat-sensitive moxibustion, such as acute cerebral hemorrhage, hypertensive crisis, sensory disturbances, serious mental diseases, etc.

What they're measuring

Systolic blood pressure

Timeframe: Baseline and months 1, 2, 3, 4, 5, and 6

Trial details

NCT IDNCT04788563

SponsorJiangxi University of Traditional Chinese Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-12-09

View on ClinicalTrials.gov More Primary Hypertension trials